- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Portable MR system aids diagnosis of rheumatic diseases
GE Medical Systems Lunar introduced the Applause, a portable MR device, at the RSNA meeting. The system is optimized for diagnosing early signs of joint erosion due to rheumatoid arthritis and other forms of autoimmune rheumatoid diseases.
GE Medical Systems Lunar introduced the Applause, a portable MR device, at the RSNA meeting. The system is optimized for diagnosing early signs of joint erosion due to rheumatoid arthritis and other forms of autoimmune rheumatoid diseases.
Images obtained with the Applause may also be used to determine the severity of disease and to monitor its progression and treatment. The system's easy portability allows transport among rooms in private-practice offices, hospitals, or clinics.
The scanner, developed by MagneVu in Carlsbad, CA, is being distributed under agreement with GE. It was first unveiled in October at the annual meeting of the American College of Rheumatology.
The Applause uses a nonhomogeneous magnetic field to image the hand, wrist, and foot. MR promises earlier detection of arthritis, potentially leading to more effective treatment of the disease, according to MagneVu. The compact, portable magnet can be rolled into any exam room. It requires no special office setup or shielding and can be plugged into a wall outlet. The unit obtains and displays images in all three planes of view and provides scans that are similar in clarity to conventional MR images, according to GE.
AI Facilitates Nearly 83 Percent Improvement in Turnaround Time for Fracture X-Rays
December 19th 2023In addition to offering a 98.5 percent sensitivity rate in diagnosing fractures on X-ray, an emerging artificial intelligence (AI) software reportedly helped reduce mean turnaround time on X-ray fracture diagnosis from 48 hours to 8.3 hours, according to new research presented at the Radiological Society of North America (RSNA) conference.
The Reading Room: Artificial Intelligence: What RSNA 2020 Offered, and What 2021 Could Bring
December 5th 2020Nina Kottler, M.D., chief medical officer of AI at Radiology Partners, discusses, during RSNA 2020, what new developments the annual meeting provided about these technologies, sessions to access, and what to expect in the coming year.
Can an Emerging PET Radiotracer Enhance Detection of Prostate Cancer Recurrence?
December 14th 2023The use of 68Ga-RM2 PET/MRI demonstrated a 35 percent higher sensitivity rate than MRI alone for the diagnosis of biochemical recurrence of prostate cancer, according to research recently presented at the Radiological Society of North America (RSNA) conference.
RSNA 2020: Addressing Healthcare Disparities and Access to Care
December 4th 2020Rich Heller, M.D., with Radiology Partners, and Lucy Spalluto, M.D., with Vanderbilt University School of Medicine, discuss the highlights of their RSNA 2020 session on health disparities, focusing on the underlying factors and challenges radiologists face to providing greater access to care.
Can AI Improve Detection of Extraprostatic Extension on MRI?
December 4th 2023Utilizing a deep learning-based AI algorithm to differentiate between diagnostic and non-diagnostic quality of prostate MRI facilitated a 10 percent higher specificity rate for diagnosing extraprostatic extension on multiparametric MRI, according to research presented at the recent RSNA conference.
Study: Regular Mammography Screening Reduces Breast Cancer Mortality Risk by More than 70 Percent
November 30th 2023Consistent adherence to the five most recent mammography screenings prior to a breast cancer diagnosis reduced breast cancer death risk by 72 percent in comparison to women who did not have the mammography screening, according to new research findings presented at the annual Radiological Society of North America (RSNA) conference.
